New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.
Physicians need to understand that a patient's faith shapes his or her understanding of illness and know how to respond when the patient attempts to evangelize during the clinical encounter.
Physicians need to understand that a patient's faith shapes his or her understanding of illness and know how to respond when the patient attempts to evangelize during the clinical encounter.
Physicians need to understand that a patient's faith shapes his or her understanding of illness and know how to respond when the patient attempts to evangelize during the clinical encounter.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
Two physicians assert that pharmaceutical companies' sponsorship of clinical conferences for residents and physicians represent a conflict of interest.